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Summary 
Hematopoietic cells present in the liver in early human fetal life were characterized by phenotypic 
analysis using a broad panel of monoclonal antibodies. Expression of very late antigen 4 and 
leukocyte function-associated antigen 3 cell adhesion receptors and 4F2 cell activation molecules 
was found in all fetal liver hematopoietic cells before acquisition of T cell-, B cell-, or myeloid- 
specific surface markers, and before the time ofintrathymic colonization. Molecular studies showed 
that expression of the interleukin 2 receptor ~  (IL-2RB) also occurred in the embryonic liver 
at this early ontogenic stage. In contrast, no expression of IL-2RoL or IL-2 transcripts was found 
in fetal liver cells, whereas transcription  of the IL-4 gene was detected in a small fetal liver cell 
subset. Putative T cell precursors were identified among the hematopoietic fetal liver cells by 
the expression of genes encoding the 3/, ~, 6, and ~" invariant chains of the CD3-T cell receptor 
(TCR) complex. However, no transcription of the polymorphic c~ and ~ TCR genes was detected. 
Functional in vitro assays further demonstrated that fetal liver hematopoietic cells from those 
early embryos were capable of proliferating in response to T cell growth factors, including IL-4 
and IL-2. However, whereas  IL-4-induced proliferation  paralleled the appearance in vitro of 
CD45+CD7-CD4  'hm cells expressing the CD14 myeloid antigen, as well as of CD34 + primitive 
hematopoietic progenitors, differentiation into CD45 +  CD7 +  CD8 +  CD3- immature T cells was 
observed when using II.-2. Moreover, coculture with thymic epithelial cell monolayers provided 
additional evidence that early fetal liver hematopoietic cells may include very primitive T cell 
precursors, which were able to differentiate in vitro into TCR oL/~/+ mature T cells. Therefore, 
our results indicate that, after triggering of the T cell-specific maturation program in primitive 
fetal liver hematopoietic progenitors, specific signals provided intrathymically by epithelial cells 
may fulfill the requirements to drive terminal differentiation of prethymically committed T cell 
precursors. 
D 
uring human fetal development, hematopoietic stem cels 
home to the fetal liver at 5-6 wk of gestation.  The 
liver then becomes, until week 24, the major site of hemato- 
poiesis in humans, supporting the proliferation of progen- 
itor cells for all hematolymphoid series (including the ery- 
throid,  myelomonocytic,  and  lymphoid lineages)  (1,  2). 
Differentiation  of fetal liver progenitors along a particular 
hematopoietic lineage is further dependent upon epigenetic 
influences provided by specific cellular microenvirouments. 
The development of immunocompetent T  lymphocytes 
occurs primarily in the embryonic thymus (3, 4). At 8.5-10 
wk of gestation,  hematopoietic precursors migrating from 
the fetal liver colonize the thymic rudiment (5), where they 
undergo a complex series of differentiation events leading to 
the expression of the TCR-CD3 complex (6,  7). Efficient 
performance of this complex program appears to be depen- 
dent upon cellular interactions between developing thymo- 
cytes and thymic stromal components (i.e., epithelial cells, 
macrophages, fibroblasts, and dendritic cells) (8). In addition, 
the coordinated production of  multiple growth factors by both 
hematopoietic and stromal thymic cells throughout ontogeny 
may be critically involved in the T cell differentiation process 
(6, 9). 
Less is known, however, about the developmental  programs 
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to drive hematopoietic stem cell differentiation towards the 
T cell lineage.  Considerable insight into this process has been 
gained by the  identification  of fetal hematopoietic  CD7 + 
cells as the earliest prethymic T  cell precursors (5,  10,  11). 
Phenotypic studies have shown that cells expressing the CD7 
T cell marker were present in the fetal liver before hemato- 
poietic cell colonization  of the epithelial  thymic rudiment 
(10, 11), and concentrated in the upper thorax mesenchyme 
just before and during the time ofT cell precursor migration 
to  the embryonic thymus  (11). Functional  studies  further 
demonstrated  that  CD7 + cells  from fetal liver and thorax 
were enriched for T  cell precursors capable of giving rise to 
mature T cells (11), indicating that T cell commitment events 
may occur very early in human ontogeny. Nonetheless, the 
observation  that  both  prethymic  and  intrathymic  CD7 + 
cells can also be driven to undergo myeloerythroid differenti- 
ation by particular combinations of cytokines (11, 12) sug- 
gested that  certain  subsets of CD7 + cells are not irrevers- 
ibly committed  to the T  cell lineage (7). 
In the present report,  phenotypic and molecular studies 
were performed to determine whether prethymic differentia- 
tion events of human T cells might be identified in primitive 
hematopoietic precursors from the early embryonic liver, be- 
fore T cell marker expression. In addition, functional studies 
were done to analyze the differentiation requirements of the 
putative T cell precursors present in the liver in early human 
fetal life. Our results showed that T cell-specific maturation 
events, including the expression of genes encoding the 3', 8, 
e, and ~" invariant  components of the CD3-TCR complex, 
were initiated early in ontogeny in fetal liver hematopoietic 
precursors that lacked CD7 molecules but expressed very late 
antigen  4  (VLA-4) 1 and leukocyte function-associated  an- 
tigen 3 (LFA-3) cell adhesion receptors. Initial differentiation 
of these primitive fetal liver hematopoietic progenitors along 
the T cell lineage was demonstrated by their ability to pro- 
liferate in response to rib2 and to give rise in vitro to CD7 + 
CD8+CD3 -  immature  T  cells.  In addition,  fully differen- 
tiated CD3-TCR c~/3 + mature T  cells were obtained after 
coculture with thymic epithelial cell monolayers plus IL-2. 
Therefore, our results provide evidence that  specific signals 
delivered by the thymic epithelium are required to drive ter- 
minal differentiation of prethymically committed fetal liver 
T  cell precursors. 
Materials  and Methods 
Cell Samples.  Human fetal tissues were obtained after legal ter- 
mination of pregnancy. Gcstational age determined by crown/rump 
length,  foot length,  and menstrual records (13) ranged from 7 to 
22 wk. Infant  thymus  samples were obtained from 1 too-old to 
3 yr-old patients undergoing  corrective cardiac surgery. Cell sus- 
pensions were obtained from thymus,  spleen, and liver samples, 
and mononuclear cells were separated by centrifugation over Ficoll- 
Hypaque (Pharmacia, Uppsala, Sweden), through which mature 
1 Abbreviations  used in thispaper: TEC, thymic epithelial cells; VLA, very 
late antigen. 
red blood ceils and hepatocytes sedimented. The cells at the inter- 
face were then washed three times in KPMI 1640 (Gibco, Paisley, 
Scotland) containing 2 mM L-glutamine, 10 mM Hepes, 100 U/ml 
penicillin, 100 mg/ml streptomycin, and 10% heat-inactivated FCS 
(Gibco) (complete medium). 
Intrathymic T cell precursors, referred to as pro-T cells (14), were 
isolated from neonatal thymi by consecutive treatments with anti- 
CDla (Nal.34),  -CD4 (HP2/6), -CD8 (B9.4), -CD3 (SPV-T3b), 
and -CD2 (Leu-5b) mAbs plus rabbit complement (scra Labs Ltd., 
Sussex, UK), as described previously (14). After Ficoll-Hypaque 
centrifugation, recovered  viable cells were treated again, in one step, 
with a cocktail of the indicated mAbs and incubated 30 rain at 
4~  with  magnetic  beads  coated  with  affinity-purified sheep 
anti-mouse  IgG (Dynabeads M-450; Dynal,  Oslo, Norway) fol- 
lowing manufacturer's recommendations. This procedure allowed 
the isolation of a highly purified preparation of pro-T cells (>99% 
CD45 +, 50-95% CD7 §  CDla-2-3-4-8-)  (14, 15). 
Activated peripheral T cells were obtained after culture of PBMC 
in complete medium  containing  1%  PHA (Difco Laboratories, 
Detroit, MI) for 4 d. 
Quantitative Flow Cytometry.  Flow cytometry studies were per- 
formed by direct or indirect immunofluorescence as described (14). 
Cells were incubated with saturating amounts of the corresponding 
mAb (Table 1) at 4~  for 30 rain, followed by two washes. FITC- 
conjugated F(ab')a goat anti-mouse  IgG (Southern Biotechnology 
Associates, Inc., Birmingham,  AL) was used as a second-step re- 
agent. For dual parameter analyses, cells stained following the de- 
scribed procedure, or directly labded with available FITC-coupled 
mAbs: FITC-GAPS.3 (Table 1) and FITC-OKT3, -OKT4, -OKT8 
(Ortho Diagnostic,  Raritan,  NJ), were further  incubated  either 
with biotin-conjugated  mAbs (3A1, MAR-108) (Table 1) followed 
by PE-coupled streptavidin (Southern Biotechnology  Associates, 
Inc.) or with available PE-coupled mAbs (T11-tLD1; Coulter Im- 
munology, Hialeah, FL; PE-I.cu-4, PE-Leu-2a, PE-Leu-3a; Becton 
Dickinson & Co., Mountain View, CA). Irrelevant isotype-matched 
mAbs (Becton Dickinson & Co.) were used as negative controls. 
Quantitation  of the surface staining of 104 viable ceils was per- 
formed using an EPICS Profile flow cytometer (Coulter Electronics, 
Hiahah, FL). Cells were considered positive for the tested antigen 
when fluorescence intensity was above the upper limit of the nega- 
tive control.  The data were computed  for graphic display using 
a program  developed in our laboratory  (46). 
Fetal Liver Cultures.  Freshly  isolated fetal liver mononuclear cells 
(2  x  106) were cultured  in 24-well macroplates (Costar,  Cam- 
bridge, MA) at 106 cdls/ml in complete medium alone, or in com- 
plete medium containing optimal mitogenic doses of either rIL-2 
(10 nM) (Hoffman-La Roche, Basel, Switzerland) or rib4 (1 nM) 
(Sandoz, Basel, Switzerland); or were cocultured with monolayers 
of the ET-VII thymic epithelial cell line (2  x  104 cells/well) in 
complete medium  with or without 10 nM rIL-2. 
Preparation of Thymic Epithelial Cell Monolayers.  Monolayers of 
thymic epithelial cells were prepared from neonatal or fetal thymi 
as previously described (47). The cultures were initiated in six-well 
plates (Costar) in D-valine-supplemented MEM (Gibco) containing 
2 mM L-glutamine, 10 mM Hepes, 100 U/ml penicillin, 100 mg/ml 
streptomycin, and 10% FCS (D-valine medium). D-valine was used 
to hinder the growth of fibroblasts without affecting that of epi- 
thelial cells (49). After 5-7 d, cells were incubated  at 37~  for 
2 d in D-valine medium  containing  5 ~g/ml mycophenolic acid 
(Sigma Chemical Co., St. Louis, MO) to further eliminate hema- 
topoietic cells. The cell monoh-yen were subsequently removed from 
the wells every 7 d by treatment with 1.5 ml/weU Puck's-modified 
solution containing trypsin and EDTA (Gibco) and, after washing, 
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typic studies of epithelial cells growing under these culture condi- 
tions were performed after 2-3 too. For phenotypic analyses, epi- 
thelial ceils, either untreated  or treated with digitonin  (0.005%) 
as previously described (49), were subjected to indirect immuno- 
fluorescence staining by using the fonowing mAbs: AE-3, anti-high 
molecular weight basic keratins; TE-3A, anti-cortical  thyrnic epi- 
thelium;  and TE-4,  anti-subeapsular  cortical and medullary epi- 
thelium (8), kindly provided by Dr. B. F. Haynes (Duke University 
Medical Center, Durham, NC); RFD4, anti- medullary thymic 
epithelium (50), the kind gift of Dr. G. Janossy (Royal Free Hos- 
pital School of Medidne, London,  UK); TE-7,  anti-mesoderm- 
derived thymic epithelium (8) (Scra Labs); TS 2/9, anti-LFA3 (41), 
kindly donated by Dr. F. Sanchez-Madrid (Hospital de la Princesa, 
Madrid,  Spain); and W6/32, anti-MHC chss I (A, B, C) (43). 
eDNA Preparation.  Total  cellular RNA was isolated from fetal 
and adult tissues by the acid phenol procedure (51). The integrity 
of mKNA  was  verified by optical  density,  ethidium  bromide 
staining, and Northern blot hybridization after electrophoresis on 
formaldehyde-agarose gels, as described dsewhere (14). Reverse tran- 
scription of total KNA (5 tLg) into single-strand cDNA was per- 
formed using AMV reverse transcriptase and oligo(dT)ls primers 
(Boehringer Mannheim GmbH, Mannheim, Germany), according 
to the manufacturer's  recommendations. 
PCR Analysis.  PCR amplifications (52) were performed with 
5% of each eDNA sample, in a 100-#1 reaction volume containing 
2.5 U ofTaq polymerase (Perkin Elmer Cetus, Norwalk, CT) and 
100 pmol of each of the two gene-specific primers.  DNA was 
amplified by 30 cycles of 940C for 1 rain,  550C for 1 rain,  and 
720C for 1.5 rain, in a thermal cycler (Perkin Elmer Cetus). PCR 
amplifications of genes encoding the 3', #, e, and ~" chains of the 
CD3-TCR  complex  and  IL-2Rot and  IL-21~  were performed 
by  using  the  following  oligonucleotide  primers:  5'  CD3-3,, 
5'-CAGGAAT~~CACGCTITIGC-3';  3' CD3-T, 
5'-CAGAAGCTTTTCCCCAATAGGTGGCGC-3';  5' CD3-~, 
5'-TTCCGGTACCTGTGAGTCAGC-3'; 3' CD3-8,  5'-GGTACA- 
GTTGGTAA_q'GC~TGC-3'; 5' CD3-e, 5'-GAAATGC~TGGTAT- 
TACACAGACACC-3'; 3' CD3-6, 5'-GC_~CTCTGTCAACATI~- 
ACCCAGTCC-Y; 5' TCR-~', 5'-CAGAAGCTTC'IV_,CCTCAGC- 
CTCIV~CT-3'; 3' TCR-~', 5'-TATGAAT/'CGCCTTTGAGTGG- 
TGAAAT-3'; 5' Ib21k~, 5'-TTCAC'IV_~GGCCGCTGGTCCCA- 
AGGGTCAG-3'; 3' IL-2Rot, 5'-GCTTGCCTGAGGCTTCTCT- 
TCACC'IGGAAA-Y; 5' IL-21~, 5'-CCAGCTGAGCTCAGAGC- 
ATGG-3'; 3' IL-21~, 5'-CCAAGTGAGTTGGGTCCTGACC-3'. 
To avoid unspliced mRNA or DNA amplification, each primer 
of every pair was located in different exons. Ib2 and IL-4 transcrip- 
tion  studies  were performed by  the  MAPPing  TM  technique 
(Clontech  Laboratories, Inc.,  Palo Alto,  CA),  using  appropriate 
oligonuchotide primers (Clontech Laboratories, Inc.). Previously 
reported  degenerate primers  (53), developed on the basis of the 
conserved sequences at the 5' end of human V~ and V~ gene seg- 
ments, in combination with either Ccz or C~ primers, enabled the 
amplification of all known human Vot and V~ chain TCIk genes. 
As described (53), these sets of primers also proved successful in 
the amplification and cloning of VDJ regions for which no prior 
sequence data are known, indicating their general applicability in 
TCR gene expression studies. 
Equivalent amounts  of eDNA among different samples could 
be  estimated  by comparable  capacity  to  act  as  substrate  for 
amplification directed by ~-actin gene-specific primers (Clontech 
Laboratories, Inc.) at 15, 20, and 30 cycles of amplification. Titra- 
tion of cycle number allowed us to perform densitometric analyses 
of the ~-actin amplifications among different eDNA samples under 
nonsaturating  conditions.  Thus,  since all samples analyzed for a 
given pair of primers were processed simultaneously, comparisons 
could be made for the expression of a particular gene in different 
cell samples. The B-actin control shown in Fig. 2 applies for studies 
shown in both Figs. 2 and 4, which were performed on exactly 
the same eDNA samples. The specificity of the amplified products 
was demonstrated by Southern blot hybridization.  PCR products 
(10 #1) were run on 1.5% agarose gels, transferred to nylon mem- 
branes, and hybridized as described elsewhere (14) using the eorre- 
sponcling gene-specifie probes. The CD3-e (54) and CD3-# (55) 
probes were the kind gift of Dr. C. Terhorst (Dana Farber Cancer 
Institute, Boston, MA), and the CD3-T (56) and TCR-~"  (57) probes 
were kindly provided by Drs. M. J. Crumpton (Imperial Cancer 
Research Foundation, London, UK) and R. D. Klansner (National 
Institutes  of Health.  Bethesda, MD), respectively. The IL-2 (58) 
and  IL-2tL8 (59)  probes  were generously  provided  by Dr.  T. 
Taniguchi (Osaka University, Osaka, Japan), and the IL-4 (60) and 
IL-2Rot (61) probes were the generous gift of Drs. K. Arai (DNAX 
Research Institute  of Molecular and Cellular Biology, Palo Alto, 
CA) and "1". Honjo (Kyoto University, Kyoto, Japan), respectively. 
Spedfie Col (62) and CB (63) probes were kindly provided by Dr. 
T. Mak (The Ontario Cancer Institute, Toronto, Ontario, Canada). 
In Situ Hybridization.  Freshly isolated hematopoietic fetal liver 
cells (10  s cells/slide) were subjected to in situ hybridization  by 
using eDNA probes hbeled with digoxigenin-11-dUTP (Boehringer 
Mannheim),  as previously described (46). Antidigoxigenin  anti- 
bodies conjugated to alkaline phosphatase (Boehringer Mannheim) 
were  used  for  the  immundogical  detection  according  to  the 
manufacturer's recommendations. The number of  positive ceils was 
determined over background labeling detected after hybridization 
of fetal liver cells with an irrelevant mouse Ig probe (]11). The CD3-e 
(54), CD3-/J (55), CD3-T (56), TCR-f (57), IL2Ro~ (61), IL-2R~ 
(59), Ib2 (58), and 1/.,4 (60) eDNA probes used in this study have 
previously proved successful in the in situ hybridizations  of in- 
trathymic T cell precursors and mature T cells, whereas background 
labeling was detected with mouse B cells (46, and our unpublished 
results). 
II.,2 Binding Assays.  Aliquots of freshly isolated fetal liver ceils 
(2  x  107) were extensively washed and treated for 3 rain at 4~ 
with 0.15 M NaC1, 0.1 M glycine (pH 4) and washed again three 
times. Ceils (106) were then incubated with serial dilutions (1 pM 
to  25  nM  final concentration)  of mI-labeled  IL-2 (Amersham 
Corp., Amersham,  UK) for 1 h at 4~  as previously described 
(15). Specifically  bound and free 12SI-labded IL-2 was determined 
by solid scintillation counting.  The calculated values for the dis- 
sociation constant  and the number of binding  sites per cell were 
derived by Scatchard computer analysis of equilibrium binding data, 
according to Munson and Rodbard (64), assuming a uniform dis- 
tribution of sites. The data were corrected for nonspecific binding 
of IL-2, determined in the presence of a 250-fold molar excess of 
unlabded rlL-2, and for the loss ofligand binding activity incurred 
during the IL-2 binding  procedure. 
Results 
Phenotypic Characterization of Primitive Hematopoietic Cells 
in Human Fetal Liver: Early Ontogenic Expression of VLA-4 
and LFA.3 Cell Adhesion Molecules.  To address the ontogeny 
of hematopoietic cells in the human fetal liver,  cytofluoro- 
metric analyses were performed in freshly isolated mononuclear 
cells from different 7-22-wk-old fetal liver samples,  using the 
panel of mAbs listed in Table 1. These studies revealed  that 
21  S~nchez et al. Table  1.  mAbs Used  for the Phenotypic Analysis of Hematopoietic Cells in Human Fetal Samples 
Differentiation  Antigen 
cluster  (CD)*  mAb  recognized  Reference 
CDla  Nal.34,T6t  T6/HTAl,gp49  16,17 
CD2  OKTll,SLeu5b,UTllt  Tll/LFA2,gp50  18,19 
CD 3  SPV  / T3b, OKT3,SLeu411  T3, gp26,20,16  20-  22 
CD4  I',IP2/6,OKT4,SLeu3a I~  T4,gp59  23-25 
CD5  OKTI,SLeulll  Tl,gp67  20,26,27 
CD7  3A1  'i  gp40  28 
CD8  B9.4, O KT8, SLeu2al1  T8, gp32  17,24,29 
CDllb  Molt  C3biR,gp155/95  30 
CD13  My7t  gp150  31 
CD14  Mo2*  gp55  30 
CD16  Leullcll  FcRIII,gpS0-65  32 
CD19  B4*  gp95  33 
CD20  BI*  p37/32  34 
CD25  MAR- 108  IL-2R~/Tac,gp55  25 
CD28  9.3"*  T44,gp44  35 
CD29  Ts2/16  VLA-/~,gp130  36 
CD34  HPCAlll  gp105-120  37 
CD38  OKT10S  T10,p45  17 
CD45  GAP8.34  T200/LCA,gp180-220  38 
CDw49d  HP2/1  VLA-4,gp150  39 
CD57  Leu711  HNK-l,gp110  40 
CD58  Ts2/9  LFA3,gp40-65  41 
CD71  OKT9S  T9/TfR,gp180  17 
-  4F21  gp120  42 
-  W6/32  ~  HLA A,B,C;gp40  43 
-  anti-HLA-DR  II  HLA-DR;gp29/34  44 
* From references 44a and 45. 
* Coulter Clone. 
$ Ortho Diagnostic (Raritan, NJ). 
U  Becton Dickinson & Co. 
American Type Culture Collection (Kockvilh, MD). 
"* New England Nuclear (Boston, MA). 
none of the fetal livers analyzed from 7 to 8 wk of gestation 
(the earliest time examined) contained cells expressing T cell 
markers on the ceil surface, as assessed by staining with mAbs 
specific  for CDla, CD2, CD3, CD4, CD8 (Table 2), CD28, 
or IL,21Lc~ (CD25) (data not shown). We observed reactivity 
of these samples neither with mAbs that recognize the early 
T lineage molecule CD7 (Table 2) nor with antibodies specific 
for myeloid (CD13, CD14), NK ceil (CDllb, CD16, CD57), 
or B ceil (CD19,  CD20) differentiation antigens (data not 
shown). Similarly, CD34 molecules (normally expressed on 
primitive hematopoietic progenitors) were rarely found in the 
fetal liver at this early gestational age, although CD34 + cells 
were  observed in older liver and spleen samples (Table  2). 
Expression of the pan-leukocyte molecule CD45 was detected 
on only a small, but measurable, fraction (0-8%) of fetal liver 
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ceils before 9 wk of gestation. The proportion of CD45 § 
cells in each particular sample was slightly higher than the 
number of cells  reactive  with an anti-HLA heavy  chain-specific 
mAb (0-4%), while expression of class II MHC molecules 
could not be detected (Table 2). With increasing gestational 
age,  the percentage  of ceils in the fetal liver expressing  the 
CD45 marker and class I MHC molecules gradually rose to 
41 and 22%, respectively, at week 22 of gestation (the latest 
gestational  age examined).  Surface expression  of the CD45 
leukocyte-associated marker paralleled the acquisition of the 
CD7 T cell molecule, which was detected on 0.5-6% of fetal 
liver cells at weeks 11-13, and reached 13% at week 22. Very 
few CD7 § ceils, however, expressed CD3 molecules on the 
membrane (Table 2). Mature T cells progressively increased 
in fetal spleen and thymus following the sequence of appear- Table  2.  $ugCace  Expression of Lyraphoid Antigens on Hematapoietic Cells  from Human Fetal Tissues 
Fetal tissue 
Liver  Thymus  Spleen 
Antigen  7-8 wk*  11-13  wk  22 wk  22 wk  22 wk 
CD45  4.5  +  3.5 (6)  10.2  _+ 4.6 (4)  33.0  +  8.5 (3)  95.0  +  2.0 (3)  47.0 (1) 
CD34  <0.1  (3)  0.5  •  0.3 (2)  6.0 (1)  ND  11.0  +  5.0 (2) 
CD7  <0.1  (6)  3.2  +  2.7 (3)  13.0 (1)  87.5  (1)  ND 
CDla  <0.1  (6)  <0.1 (3)  3.0  _+ 2.0 (3)  82.0  +  5.0 (3)  1.5  +  0.3 (3) 
CD2  <0.1  (6)  1.5  •  0.4 (3)  8.5  +  2.5 (3)  96.0  +  2.0 (3)  15.5  +  4.5 (3) 
CD3  <0.1  (6)  1.3  +  0.2 (3)  5.1  •  1.1 (4)  71.5  •  4.5 (3)  12.5  •  5.0 (3) 
CD4  <0.1  (6)  <0.1 (3)  7.5  +  4.0 (4)  70.5  •  8.0 (3)  8.5  •  2.0 (3) 
CD8  <0.1  (6)  <0.1 (3)  6.5  +  2.0 (4)  82.5  •  4.5 (3)  7.5  •  2.0 (3) 
MHC class I  2.3  •  1.3 (5)  11.5  •  4.5 (3)  15.0  •  7.0 (3)  17.5  +  2.5 (2)  19.5  •  2.5 (2) 
MHC class II  0.5  •  0.3 (4)  4.4  •  2.8 (3)  8.0  •  3.0 (2)  1.0  •  0.5  (2)  9.5  •  1.5 (2) 
Values are expressed as the mean + SEM of the percent of nucleated positive cells determined by flow cytometry. Number of fetal samples tested 
is in parentheses. 
* Gestational age (wk) was determined by crown/rump length, foot length, and menstrual records. 
ance of CD7 + T  cell precursors in fetal liver.  As shown in 
Table 2, a phenotypic distribution similar to that of the neo- 
natal  thymus was observed in fetal thymi at week 22, and 
both mature B and T cells were detected in the spleen at this 
gestational  age. 
In spite of the very low proportion of liver cells that ex- 
press conventional leukocyte markers in early fetal life, 4F2 
molecules, commonly expressed on rapidly dividing and ac- 
tivated cells, were detected on most (>95%) liver cells from 
as early as  7-8-wk-old embryos. Expression  of transferrin 
receptors (Tfr, CD71) was also detected on a significant frac- 
tion (75-90%) of fetal liver cells (Fig. 1). Up to 50% of the 
fetal liver cells were in the S or G2  + M  phases of the cell 
cycle (data not shown), which correlated with their activa- 
tion/proliferation surface phenotype. Surprisingly, a majority 
of hematopoietic fetal liver cells (>99%) at this gestational 
age also showed high levels of expression of different cell adhe- 
sion receptors. As shown in Fig. 1, LFA-3 (CD58) and the 
B1 subunit of the integrins  (VLA-~, CD29) were detected 
in virtually all fetal liver cells. The expression of CD29 directly 
parallded that of the VLA-4 (CDw49d) member of the/31 
integrin subfamily (Fig.  1), whereas the expression of other 
~1  integrins,  such  as  VLA-1,  was  undetectable  (data  not 
shown). 
Prethymic Transcription of Genes Encoding the % d, e, and ~" 
Invariant Chains of the CD3.TCR Complex in the Early Human 
Embryonic Liver.  To analyze whether T  cell-spedfic matu- 
ration events can occur in the human fetal liver before the 
acquisition  of conventional  T  lineage markers,  we studied 
the expression of genes coding for the CD3-TCR complex 
molecules in hematopoietic cells present in the liver from as 
early as at 8 wk of gestation,  when no hematopoietic cell 
precursors have yet colonized the thymic rudiment. Transcrip- 
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tion of genes encoding the %  8, 6, and ~" invariant compo- 
nents of the CD3-TCR complex was assessed by the PCR 
technique (52) (Fig. 2). Aliquots of single-strand cDNAs syn- 
thesized from similar amounts of total RNA obtained from 
freshly isolated cells were amplified by using specific oligo- 
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Figure I.  Expression  of  activation  antigens  and  adhesion  molecules  on 
early  human fetal  liver  hematopoietic  ceils.  Freshly  isolated  8-wk  fetal  liver 
cells  were stained  with the  indicated  mAbs followed  by  FITC-conjugated 
goat  anti-mouse  F(ab')2  IgG.  The number of  positive  ceils  (98% 4F2  +, 
82% Tfr  +  ,  >99% LFA3*, 98% VLA-~J  +, 97% VLA-4  +) was deter- 
mined over  background staining  observed  with irrelevant  mAbs used  as 
negative controLs,  Results  are xq~.-sentative  of  five  independent ex']:~-iments. Figure  2.  Expression of genes encoding  the %  ~, e, and ~" invariant 
chains of the CD3-TCR complex in human fetal liver hematopoietic cells. 
Amplification of identical amounts of eDNA obtained from the indicated 
RNA samples was performed using CD3-% CD3-~, CD3-e, and TCR-~" 
chain-specific oligonucleotides. PCR-amplified products (10/A) were sub- 
jected  to Southern  blot hybridizations  using gene-specific probes. Films 
were exposed for I-6 h and 1-4 d (left and right), respectively. The capacity 
ofcDNA generated from RNA to be amplified by PCR was in every case 
tested first by use of 3-actin-specific primers and subsequent hybridization 
with a 3-actin probe. 3-actin films were exposed for 30 rain (left and right). 
Use of the 1-kb ladder marker indicated that products  detected were of 
the expected size. 
nudeotide primers  (see Materials and Methods). Checking 
of equivalence  of  cDNAs was assessed  by use of specific  primers 
for the/3-actin gene (Fig. 2), as described in Materials and 
Methods. All primer combinations failed to amplify a product 
when irrelevant eDNA (from mouse hybridoma X63) was 
used, or when eDNA was omitted from the reaction.  The 
specificity of amplification was determined by further elec- 
trophoresis,  blotting, and hybridization of amplified prod- 
ucts with specific probes. 
As shown in Fig. 2, CD3-3,-, CD3-~-, CD3-e-, and TCR- 
~'-specific bands were detected in the following samples: (a) 
Jurkat T cells and PHA-activated  peripheral Y cell blasts (PHA- 
B),  induded in the study as positive  controls;  (b) mature 
CD3 +  thymocytes  and  CD7+CD3 -  intrathymic  T  cell 
precursors (referred to as pro-T cells; reference 14), obtained 
from a 6-too-old thymus; and (c) fetal thymus and spleen from 
a 22-wk-old embryo. In addition, expression  of genes encoding 
all ~,/~, e, and ~" invariant chains of the CD3-TCR complex 
was dearly evident in the fetal liver at all tested gestational 
times (8-22 wk), although less intense PCR signals requiring 
longer film exposures were observed in the earliest (8-11-wk) 
Figure  3.  Analysis of the expression of  TCR a and TCK ~ IkNA tran- 
scripts in human fetal hematopoietic tissues. Equivalent amounts of eDNA 
obtained from the indicated sources were PCK amplified using pan Va 
or pan V/3 primers, in combination with Co~ or CB gene-specific primers, 
respectively. Southern blot hybridization of PCK amplifications was then 
performed using Ca or C]3 probes. Exposure to film was for I  and 2 h, 
respectively. ~-actin gene PCK amplifications of the expected size verified 
the integrity of eDNA samples. 
fetal liver samples (Fig. 2). Comparable results were obtained 
with independent RNA preparations  from the same fetal 
sample, or from different  samples at  equivalent  ontogenic 
stages. Parallel analyses of CD3-TCR gene expression carried 
out by in situ hybridization independently confirmed the data 
derived by PCR (see below). Our results, therefore, provide 
molecular evidence that at early ontogenic stages, when T 
lymphoid markers are undetectable  on the cell surface, the 
transcription  of genes encoding the 3', 6, and ~ chains of the 
T cell-specific CD3 complex and the TCR-assoeiated ~" chain 
has already been initiated in the human fetal liver in putative 
prethymic T  cell precursors. 
In contrast to the early ontogenic expression observed for 
the genes encoding the invar/ant components of the CD3- 
TCR complex,  no rearrangement of genes coding for the 
polymorphic a  and/~ chains of the TCR could be detected 
by Southern blot hybridization in the 8-wk-old fetal liver 
samples studied. Neither did we find expression of functional 
TCR ce and TCR 13 RNA transcripts  in those samples by 
Northern blotting (data not shown). To confirm these nega- 
tive results, functional V-(D)-J-C rearrangements were sought 
by the use of a highly sensitive PCR technique proved to 
detect transiently expressed rearranged  genes in very small 
24  Human Fetal T  Cell  Ontogeny blot hybridization (Fig.  4).  As described in Materials and 
Methods, equivalence in the amount ofcDNA could be esti- 
mated by their comparable capacity to act as substrate for 
amplification directed by fl-actin primers.  This control is 
shown in Fig. 2. As expected, these studies showed that high 
levels of I1.-2 transcripts were expressed in activated periph- 
eral T  cells,  as well as in neonatal intrathymic pro-T cells, 
but  not  in  CD3 +  mature  thymocytes  (Fig.  4).  Strong 
specific bands were also detected in the fetal thymus and fetal 
spleen samples analyzed at 22 wk of gestation, whereas a weak 
hybridizing band was detected in the liver at this gestational 
age (Fig.  4).  By contrast,  no IL-2 transcripts could be de- 
tected in the liver from 8-wk- and 11-wk-old fetuses (Fig. 
4), even after 60 cycles of amplification and upon long (10 d) 
exposure time (data not shown). This suggests that IL-2 gene 
expression detected in liver and spleen at 22 wk most prob- 
ably reflected recirculating intrathymic precursors seeding those 
peripheral organs. In addition, IL-4-gene expression was de- 
tected in all 8-, 11-, and 22-wk-old fetal liver samples exam- 
Figure 4.  Cytokine  gene  expression  in human  fetal  hematopoietic  tissues. 
cDNA obtained  from  the indicated  samples  was PCK amplified  using  IL.2, 
IL4, II..2Rot, and IL-2RB  gene-specific  primers.  Amplified  products  were 
then subjected  to Southern  blot hybridization  using gene-specific  probes. 
Films were exposed  for 1-3 d. cDNA sample  integrity and checking  of 
equivalence  of cDNAs was assessed  by fl-actin  gene amplifications.  This 
control is shown in Fig. 2 in a different  order. 
percentages of cells in embryonic tissues (65).  As described 
in Materials and Methods, amplifications were performed by 
using pan Vot or pan V3 primers specific for all human Vot 
or  Vfl  gene families,  in  concert  with  either  Cox  or  CB 
gene-specific primers (53), and followed by blotting and hy- 
bridization either with Cc~ or Cfl gene-specific probes. The 
results confirmed the absolute lack of  expression of  both rear- 
ranged TCR r  and TCR/3 genes in the fetal liver by 8 wk 
of gestation (Fig. 3). As a negative control, TCR transcripts 
were also undetectable in the lymphoblastoid B cell line JY. 
In contrast, both c~ and/3 TCR gene transcripts were clearly 
evident in the liver,  and strongly expressed in the thymus 
and spleen from a 22-wk-old embryo, as well as in CD3 + 
neonatal thymocytes (Fig. 3). Identical results were obtained 
independently of the amount of PCK products loaded, and 
upon longer film exposures (10 d;  data not  shown). 
Developmental  Regulation of Cytokine/C2/tokine  Receptor  Gene 
Expression.  Studies performed in the mouse embryo have 
shown that the genes coding for certain cytokines and their 
receptors, particularly I1.-2 and IL-4, are activated in vivo in 
the fetal thymus during early T  cell development. Similar 
ontogenic studies have not been performed in humans as yet. 
Thus, cDNA samples identical to those used for Fig. 2, were 
amplified by PCK with appropriate oligonucleotide primers, 
and the amplified products were further analyzed by Southern 
Figure 5.  Expression  of CD3 and IL-21~ transcripts in human fetal 
liver hematopoietic  cells. Cytocentrifuge  preparations  of freshly  isolated 
8-wk-old fetal liver cells (105 cells/slide)  were hybridized  in situ with 
cDNA  digoxigenin-11-dUTP-labeled  probes specific  for the genes  encoding 
the e (.4), 8 (B), 3, (C), and ~'(D) invariant  chains  of the CD3-TCK com- 
plex, and for the IL.2Ka (E) and IL-2RB (F) genes. An irrelevant  mouse 
Ig probe 011) was included  as negative  control (G). Representative  fields 
are shown (￿  440). 
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pro-T cells, but not in mature thymocytes (Fig. 4). 
Parallel studies also showed that expression of the gene 
coding for the light chain of the II.-2R (IL-2Rct; p55, Tac)  ~  _~ 2.40- 
was not detectable in the fetal liver at any gestational age,  ~  2.o0_ 
neither in the early intrathymic pro-T cell subset, nor in ma-  _~  o  ture thymocytes (Fig. 4), independendy of the amount of 
PCR product loaded, and even upon long exposure times.  ~  1.4o_ 
Weak specific bands were observed, however, in fetal thymus  ~  l o0_ 
and spleen, while high levels of Ib21kct transcripts were pro-  ca  z 
duced in activated peripheral T cells. Expression of the gene 
encoding the heavy IL-2R chain (IL-2RB; p75) was observed  m  0.40_ 
in all fetal and adult tissues analyzed, including the youngest 
(8 wk) fetal liver samples (Fig. 4), and a similar pattern of 
expression was detected for the IL-4R gene (data not shown). 
In situ hybridization studies were next performed to ob- 
tain quantitative information on the expression of the ana- 
lyzed genes, and to determine whether the observed pattern 
of cytokine production and cytokine receptor expression could 
be selectively attributed to a single subset of hematopoietic 
fetal liver cells, particularly to putative T cell precursors. Ex- 
pression of genes encoding the e,/~,  and 3' CD3 subunits 
was detected in 40 +  7, 35  +  5, and 15 +_ 5%, respectively, 
of hematopoietic cells within the 8-wk-old fetal liver, whereas 
~" gene transcription was restricted to 6-8% of the cells (Fig. 
5). As previously shown by PCR, no IL-2Rtx expression could 
be found in the embryonic liver by in situ hybridization (<1% 
of positive cells).  In contrast,  IL-2R/3 transcripts were de- 
tected in a high proportion (70  _+  7%)  of fetal liver cells 
(Fig. 5).  Expression of IL-4 and IL2 genes was also found 
to be limited to 15-20  and <1%,  respectively, of the cells 
(data not shown). These quantitative results indicate that at 
least a minor fraction of putative fetal liver T cell precursors, 
shown to transcribe the CD3-e  and/or CD3-6 genes, may 
also express Ib2RB, but not Ib2Rtx or Ib2 transcripts. How- 
ever, similar crosscorrelation analyses could not be performed 
for the Ib4  gene. 
Surface Expression of IL2P-43 Molecules on Hematopoietic 
Cells within the Early Human Embryonic  Live~.  The functional 
relevance of IL-2RB gene expression detected in the early em- 
bryonic liver was assessed at the protein level by IIr  binding  CD45 
assays performed in freshly isolated fetal liver cells. Because  CD34 
of the low numbers of mononudear cells obtained from the  CD7 
youngest available fetal liver samples, Ib2 binding assays were  CDla 
carried out on hematopoietic cells from 13-wk-old fetal livers. 
As shown in Fig. 6, Scatchard analysis of equilibrium binding  CD2 
data obtained by using serial dilutions of 12SI-labeled human  CD3 
rib2 (1 pM to 25 nM final concentration) indicated that fetal  CD4 
liver cells displayed 1,605 intermediate-affinity (Ka, 936 pM)  CD8 
IL-2 binding sites per cell (assuming a uniform distribution  CD14 
of sites in all cells) (Fig. 6). However, since Ib2P~ transcripts  IL-2gct 
were expressed at most in 70% of fetal liver cells,  a higher 
number of II--2RB molecules per cell may be expressed by 
a subset of fetal liver cells. According to the observed lack 
of IL-2tkct transcripts, low and high affxnity IL-2Rs were not 
detected (Fig. 6). Therefore, Ib2RB is the chief IL-2 binding 
component expressed on the surface of hematopoietic fetal 
liver cells. 
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Figure 6.  Expression  of Ib2RB molecules on early human fetal liver 
hematopoietic cells. IL-2 binding assays were performed in fleshly isolated 
13-wk fetal liver cells incubated with serial dilutions (1 pM to 25nM final 
concentration) of lzSI-labeled II~2. The calculated values for the dissocia- 
tion constant and for the number of IL-2 binding sites were derived by 
Scatchard computer analysis of equilibrium binding data. Similar results 
were obtained in three independent e~periments. 
Hematopoietic Cells Present in the Early Human Fetal Liver 
Contain Precursors of CD7+ CD8+ CD3-  Immature T  Cells. 
Fetal liver cells were next functionally assayed for their ability 
to proliferate to defined T cell growth factors. Thus, fleshly 
isolated mononudear cells from 8-wk fetal liver samples were 
cultured in vitro with either Ib2 or IL4; i.e., two lymphokines 
known to play a key role as growth factors for intrathymic 
Table  3.  In  Vitro Induction of T  Cell Marker Expression 
on Human  Cultured Fetal Liver Cells 
Culture  Conditions 
Antigen  -  IL-2  IL-4  ET-VII  IL-2  +  ET-VII 
98  97  70  98  94 
ND  8  38  45  ND 
<0.1  94  5  63  53 
<0.1  <0.1  <0.1  <0.1  <0.1 
<0.1  12  <0.1  <0.1  45 
<0.1  <0.1  <0.1  <0.1  31 
27  dull  <0.1  25 dull  <0.1  30  h'isht + 9  dull 
<0.1  63  <0.1  <0.1  12 
ND  5  30  ND  9 
<0.1  3  <0.1  ND  47 
Shown are percentages of positive cells analyzed by flow cytometry. Freshly 
isolated 8-wk fetal liver cells (l(F/ml) were cultured (15 d) in medium 
alone or in medium containing either rlL-2 (10 nM) or rIL-4 (1 nM), 
or were coeukured with monohyers of the ET-VII thymic epithelial cells 
(2  x  104 cells/well) in medium either with (20 d) or without (15 d) 
10 nM rIL-2. Results are representative of three independent experiments. 
26  Human Fetal T  Cell Ontogeny T  call precursors in both mice and humans (6).  Although 
functional responses varied between different samples, a dose- 
dependent ceUular proliferation was repeatedly observed in 
cultures set up with either IL-2 or IL-4. To determine the 
phenotype of hematopoietic cells within the embryonic liver 
able to proliferate in response to these cytokines, the expres- 
sion of distinct differentiation molecules was next analyzed 
by flow cytometry after culture in the presence of optimal 
mitogenic doses ofrlL2 (10 nM) or rlL-4 (1 riM). A gradual 
increase in the expression of MHC class I and CD45 mole- 
cules was observed in both culture conditions, as well as in 
cultures devoid of exogenous lymphokines. CD45 + leuko- 
cytic ceUs arising in  these cultures reached maximal levels 
(g98%)  at days 8-15  (in five different experiments) (Table 
3). The acquisition of lineage-specific differentiation antigens 
and the quantitative outcome of the progeny differed, how- 
ever, between IL-2- and IL-4-driven  cultures. Upon culture 
with IL-2, acquisition of CD45 molecules parallded the ex- 
pression of the CD7 T cell marker and, thus, both molecules 
were coexpressed on most (94%) calls by day 15 (Table 3, 
and Fig.  7).  In contrast, no CD7 expression was detected 
Figure 7.  Hernatopoietic  cells from 8-wk human fetal liver contain 
precursors ofCD7+CDS+CD3  - immature  T cells. Freshly  isohted 8-wk 
fetal liver  cells displaying  the phenotype  shown in Table 2 were  cultured 
with rib2 (10 nM) for 15 d. Two-color  immunofluorescence  analyses  were 
then performed  using  the following  combinations  of  mAbs: FITC-GAPS.3 
(anti-CD45) and biotin-coupled  3A1 (anti-CDT)  plus streptavidin;  FITC- 
OKT8 (anti-CDS)  and PE-Leu-3a  (anti-CD4); FITC-OKT3 (anti-CD3) 
and Tll-RD1  (anti-CD2); and MiK-3I (anti-IL-21~) plus FITC-goat 
anti-mouse F(ab')2 IgG and biotinihted  MAR-108 (anti-IL-2Ro~)  plus PE- 
streptavidin. Identical results were obtained in three independent ex- 
periments. 
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in the absence of exogenous lymphokines, and rare (<5%) 
CD7 + cells were observed after supplementation with Ib4 
(Table 3). Interestingly, the lack of CD7 molecules in both 
culture conditions correlated with the acquisition of low levels 
of CD4  molecules  (CD4  a~u) on  a  significant  proportion 
(g30%)  of CD45+CD7 -  cells.  These cells also  expressed 
variable levels of CD14 molecules (Table 3),  classically  ad- 
scribed to  the myeloid lineage.  Rare CD4  aun and CD14 + 
cells were also  observed at initial periods of culture in the 
presence of IL-2. However, the increase in CD7 molecules 
in  IL-2 driven  cultures  paralleled  a  gradual  decrease  in 
CD14 + calls (Table 3). Special mention also has to be made 
of the differential expression of CD34 molecules, norrnally 
expressed on primitive hematopoietic stem cells, in cultures 
supplemented with IL-4 (38%)  or II~2  (8%)  (Table 3). 
Our functional data demonstrated that hematopoietic cells 
found in the fetal liver as early as 8 wk of gestation can give 
rise to cells of the T call lineage. This was further supported 
by the observation that acquisition of CD7 molecules was 
followed by the expression of low levels of CD2 and high 
levels of CD8 T  cell antigens on 12 and 63%,  respectively, 
of Ib2-cultured fetal liver cells, whereas CD2 + and CD8 + 
cells were not detected in cultures devoid of Ib-2 or in the 
presence of IL-4 (Table 3). It must be stressed,  however, that 
the CD8 + T  cell subset comprised large-sized blastic cells 
that did not include mature T  ceils,  since no expression of 
the CD3-TCR complex was detectable (Table 3, and Fig.  7). 
CD7 +  CD8 ~  CD3-  cells lacked the IL-2Rot (Table 3), while 
most cells in the culture (79%) were reactive with a recently 
available  anti-Ib2R/J  mAb (66)  (Fig.  7). 
CD7-  Hematopoietic Cells  from 8-wk Fetal Liver Give Rise 
to TCR cr/~ § Mature T  Cells in the Presence of Thymic Epi. 
thelium.  The finding that CD7+CD8+CD3 -  immature T 
cells,  but  not  mature T  lymphocytes, were derived from 
8-wk-old fetal liver hematopoietic precursors in IL-2-driven 
cultures led us to analyze whether additional costimulatory 
signals delivered in vivo within the thymic microenvironment 
were required to efficiently drive terminal differentiation of 
primitive fetal liver T  cell precursors into TCK-CD3 + ma- 
ture T  cells in vitro.  To this end, we prepared monolayers 
of thymic adherent stromal cells derived from neonatal and 
fetal thymi. Hematopoietic cells were depleted from these 
preparations by treatment with mycophenolic acid (see Ma- 
terials and Methods).  After 3  mo of culture,  stromal cell 
preparations were shown to be homogeneous for the expres- 
sion of cytokeratins recognized by the AE-3 mAb (>95% 
AE3 +),  as  well as  for the lack of hematopoietic antigens 
(<0.1%  T  cell-,  B  cell-,  or myeloid-specific markers)  or 
fibroblast-specific  markers  (<5%  TE-7+),  with  all  these 
criteria supporting their thymic epithelial origin. The capacity 
of these thymic epithelial cells (TEC) to support T cell differen- 
tiation was assessed in vitro by coculturing freshly isolated 
8-wk fetal liver mononuclear cells with monolayers of estab- 
lished TEC. All experiments reported in this study were per- 
formed with a TEC preparation (ET-VII) that was homoge- 
neous for the expression of  MHC class I and LFA,3 molecules 
and expressed both cortical and medullary thymic epithelium 
markers:  100%  AE-3 +,  90%  TE-4 +,  20%  RFD4 +, 30% TE-3 + , <1% TE-7 +  . As assessed by PCR, ET-VII cells were 
also shown to transcribe the IblB, I1.3, Ib6, and II-7 genes, 
while transcription of I1.2 and I1.4 was not detected (data 
not shown). 
Fetal liver cells cultured in the presence of ET-VII epithe- 
lial cells without exogenous cytokine supplementation showed 
limited proliferative responses. This hampered performing ex- 
tensive phenotypic analyses,  although expression of CD45 
and MHC  class  I molecules could be detected in a major 
proportion of cultured cells (Table 3, and data not shown). 
CD34 molecules were also found on up to 45% of cultured 
fetal liver cells, while no expression of T  cell markers such 
as CD2, CD3, CD4, or CD8 was detected during the cul- 
ture period. By contrast, CD7 expression increased throughout 
culture, and was detected on 63%  of cells at day 15 (Table 
3). Since high proliferation of fetal liver cells was observed 
in response to ri1.2, phenotypic studies were next performed 
in cultures set up in the presence of ET-VII epithelial cells 
plus 10 nM ri1.2. Fetal liver cells growing under these cul- 
ture conditions showed proliferation kinetics similar to those 
observed in the presence of 11.2 alone. Cellular proliferation 
also  paralleled a sequential acquisition of CD45  and CD7 
molecules, which were first detected on 49 and 14% of cells, 
respectively, at day 7, and reached 94 and 53% of cells, respec- 
tively,  at day 20 (Table 3, and Fig. 8). Expression of CD45 
and CD7 was followed by the acquisition of CD2  and 11. 
2Rot molecules by a variable proportion of fetal liver cells 
(17 and 15%, respectively, at day D), that increased throughout 
culture (45 and 47% of cells, respectively, at day 20) (Table 
3).  Thus,  after 20  d  of culture,  most  CD45+CD7 +  cells 
(85%) also expressed CD2 molecules in high levels, and some 
of them (11%) did so in low levels. As shown in Fig. 8, ex- 
pression of I1.2Rc~ was detected in the fetal liver subset shown 
to coexpress  high CD2 levels. 
More importantly, all these phenotypic changes were shown 
to precede the appearance of CD3 + mature T  cells  in the 
cultures (12 and 31% of ceUs at days 13 and 20, respectively) 
(Table 3). Most CD3 + cells coexpressed the TCR or//3 (Fig. 
8), as assessed by staining with the BMA031 mAb (67), while 
few, if any, TCR 3,/8 + cells were detected throughout cul- 
ture (data not shown).  Acquisition of the CD3-associated 
TCR cx/B complex correlated with the differentiation of fetal 
liver cells into single-positive cells expressing high levels of 
CD4  (CD4bng  ht)  (Table  3).  In  fact,  most  CD4b~  ht  cells 
(81%), but not the small fraction of CD4  d~ cells detected 
in these cultures, coexpressed CD3  (Table 3,  and data not 
shown). As expected from the observed CD3 vs. CD4 distri- 
bution,  few CD8 + cells  (<2%)  were detected within  the 
CD3 §  subset.  It is  also  noteworthy that  no expansion of 
CD8+CD3 -  immature T  cells  was  observed throughout 
culture in the presence of epithelial cells,  although a small 
cell fraction (12%) displaying this phenotype was observed 
at day 20 (Table 3). Two-color flow cytometry analyses showed 
a mutually exclusive distribution of CD4 and CD8 differen- 
tiation antigens (Fig. 8). Coexpression of  both CD4 and CD8 
molecules was never detected at any tested culture times (days 
7-20),  suggesting  that  CD4 +CD8 +  double-positive  cells 
were not generated throughout culture. Accordingly, CDla 
expression,  generally  associated  with  the  double-positive 
phenotype, was not found in our cultures (Table 3). Finally, 
CD14 and CD4  a~ expression  was observed in a small subset 
(9%) of CD3-  fetal liver cells. This suggests that, in addi- 
tion to T cell differentiation, myeloid differentiation was also 
driven in cultures where epithelial cells were present. 
Figure 8.  Human  fetal  liver hematopoietic  precursors  differentiate  in 
vitro into CD3-TCR ol/~ + mature  T cells in the presence  of thymic  ep- 
ithelial  cells. Freshly  isolated  8-wk  human  fetal  liver  cells  were  cocultured 
with monolayers  of the ET-VII thymic  epithelial cells in medium  con- 
taining 10 nM rlL-2. After 20 d of culture, two-color  flow cytometry 
analyses  were  IX-donned  using  the following  combinations  of  mAbs: FITC- 
GAPS.3 (anti-CD45)  and  biotinilated  3A1 (anti-CD7)  plus  PE-streptavidin; 
FITC-OKT4 (antiqZD4)  and PE-Leu-2a  (anti-CDS);  BMA031 (anti-TCIL 
or//3) plus FITC-goat anti-mouse  F(ab')2 IgG and PE-Leu-4  (anti-CD3); 
and FITC-MAK-108 (anti-IL-21Lcx)  and Tll-RD1  (anti-CD2). Similar 
results were obtained in three independent  experiments. 
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Discussion 
In the present study, phenotypic, molecular, and functional 
approaches have been used to investigate maturation events 
that occur at very early stages in human fetal T cell ontogeny. 
Flow cytometry analyses of hematopoietic cells arising in the 
liver during human embryogenesis showed that neither T 
cell-, B cell-, nor myeloid lineage-restricted markers were 
expressed by fetal liver cells before 8 wk of gestation. How- 
ever, a surprisingly high expression of the 4F2 molecule, as 
well as of certain cell adhesion receptors (including LFA-3 
and VLA-4), was detected on the surface of virtually all fetal 
liver  cells  at  this  early  embryonic  stage.  LFA-3+VLA  - 
4 +  4F2 + fetal liver cells may contain multipotent hematopoi- 
etic progenitors,  as  those  molecules are  also  detected on 
CD34 +  hematopoietic  stem  cells  from  the  human  bone marrow (our unpublished results).  In addition, expression 
of VLA-4 molecules has also been shown in murine bone 
marrow lymphomyeloid precursors (68). Last, Tfr molecules 
were detected on a significant fraction of fetal liver cells, sug- 
gesting that they may include Tfr-bearing erythroid precursors 
and, to a lesser degree, CFU-GM progenitors (69, 70). Since 
Tfr are also expressed on the most immature human thymo- 
cytes (14), early T cell precursors, lacking lineage-restricted 
markers, may reside within the Tfr + fetal liver cell subset. 
Despite the lack of T  lineage-restricted markers on fetal 
liver cells from early (7-8-wk) embryos, our molecular studies 
provided evidence that T  cell-specific differentiation events 
were initiated in the human fetal liver before the time of in- 
trathymic colonization. RNA transcripts for the %/~, e, and 
~" chains of the CD3-TCR complex were consistently detected 
in variable numbers of 8-wk-old fetal liver cells. This finding 
could suggest that transcription of genes encoding all four 
invariant CD3-TCR components may occur within a discrete 
subset of putative T cell precursors. However, the possibility 
that they are independently expressed by different cell types 
cannot be formally excluded. Fetal liver prethymic T  cell 
precursors have been previously identified as a minor subset 
of CD7 + cells expressing cytoplasmic CD3-e (cCD3-e) mol- 
ecules (10). However, cCD3-e expression does not prove T 
cell lineage commitment, since it can also occur in CD7 § 
immature thymocytes that display phenotypic and functional 
features of NK cells, but lack CD3-3, and CD3-/~ mRNA 
(71, and our unpublished results). Our finding in fetal liver 
of CD3-3, and CD3-/~ transcripts further supported the fact 
that certain fetal liver hematopoietic progenitors represent 
an early CD7-  maturational step towards mature T  cells. 
Indeed, CD7-  stem cells containing T  cell precursors may 
exist in vivo,  since CD7-depleted cells  from human bone 
marrow are still able to reconstitute all hematopoietic lineages 
(72).  Our results also showed that %/~, e, and ~" gene tran- 
scription in fetal liver cells preceded the expression of TCR-ot- 
and TCR-3-rearranged genes. This gene expression pattern 
closely resembles that of intrathymic T cell precursors, which 
contain mature CD3 transcripts but not TCR-o~ or TCR-fl 
ones (14). Taken together, these data indicate that the tran- 
scription of genes coding for the invariant CD3-TCR com- 
plex components occurs early in human ontogeny in certain 
fetal liver cells, which we believe constitute prethymic T cell 
precursors. In contrast, the expression of genes encoding the 
a  and ~  polymorphic subunits  of the TCR  appears  as a 
thymus-restricted T  cell maturation event. 
Parallel molecular analysis of the transcription of genes en- 
coding IL-2, IL-4, and their corresponding receptors allowed 
us to investigate the developmental regulation of the activa- 
tion of these cytokine pathways. As previously observed in 
the mouse (6, 9), our studies revealed that II..2 and IL.2Roe 
transcripts were absent in the human fetal liver. In contrast, 
both genes were expressed in the fetal thymus, but not in 
mature thymocytes, suggesting that they are specifically in- 
duced intrathymically in early T cell precursors. An interesting 
finding was the presence of IL-2R3 transcripts in all fetal tissues 
analyzed, including the earliest fetal liver samples.  In fact, 
expression of the Ib2R~ gene was detected in most (70%) 
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fetal liver cells from 8-wk-old embryos. We believe that these 
cells transcribing the IL-2R3 gene contain the proposed subset 
of fetal liver T cell precursors, and functional data using Ib2 
lend further support to this notion (see below). However, 
the quantitative results on the transcription of CD3-TCK genes 
do not allow us to make absolute correlations,  since only ,040, 
35,  15, and 8%  of fetal liver cells transcribed the e,/~, % 
and ~"  genes, respeetivdy. These results also suggest that Ib2R3 
gene expression in fetal liver cells may reflect a common de- 
velopmental feature of hematopoietic progenitors for different 
cellular lineages. 
Molecular studies also revealed that activation of the II.-4 
pathway was induced in fetal liver at 8 wk of gestation. Since 
II:4 transcripts were detected in a low fraction (15-20%) of 
fetal liver cells (data not shown), these analyses did not reveal 
the cellular source of II.-4 gene expression within the human 
fetal liver. Therefore, primitive T cell precursors, but also other 
hematopoietic cells shown to transcribe the II.~4 gene (such 
as basophils and mast cells; 73), may be included in the Ib4- 
producing fetal liver cell subset. 
Additional evidence that primitive T cell precursors were 
indeed present in the human fetal liver as early as 8 wk of 
gestation was provided by functional in vitro studies showing 
that fetal liver hematopoietic cells were able to proliferate and 
to differentiate along the T  cell lineage. Cell proliferation 
was sustained by IL-2, as well as IL-4, for at least 5 wk. These 
studies, however, did not address whether a single fetal liver 
subpopulation is responding to both cytokines or, alterna- 
tively, different hematopoietic precursors selectively respond 
to particular soluble mediators through the corresponding 
specific receptors.  In favor of the last possibility, we have 
observed that phenotypically distinct fetal liver cells proliferated 
in response to IL-2 or Ib4.  IL-4-induced growth paralleled 
the appearance in vitro of cells expressing myeloid-associated 
antigens. This finding supports the proposed role of IL4 as 
a stimulatory factor for myeloid precursors (74).  IL-2-pro- 
liferating cells, however, mostly acquired CD7 and CD8 T 
cell markers, and some of them also expressed CD2 mole- 
cules. Interestingly, similar CD8 + single-positive immature 
T cells have been characterized in the rat and mouse thymus 
as the immediate precursors of CD4 § CD8 + double-positive 
cortical thymocytes (75).  The immature T  cell phenotype 
of the fetal liver cells proliferating to I1.-2, together with the 
finding that most of them, as shown in intrathymic T  cell 
precursors (15), expressed the ID2R3, further suggests that 
precursors of the T cell lineage are included in the Ib2RB + 
subpopulation detected in the early human fetal liver. 
The preferential differentiation of CD7 + cells at the ex- 
pense of CD14 §  and CD4  dull cells observed in II~2-driven 
cultures could indicate that, in vivo, availability  of IL-2 by 
primitive fetal liver T  cell precursors may be important in 
tilting the T  lymphoid vs. myeloid differentiation balance. 
However, terminal differentiation of fetal liver precursors into 
mature T cells was never observed in vitro upon culture with 
Ib2  and,  therefore, other signals provided by the thymic 
microenvironment may be involved in the process.  Accord- 
ingly, mature CD3-TCR o~/3 + T cells appeared in our cub 
tures when thymic epithelial cells (ET-VII) were provided. The lack of both TCR ot and TCK 3  transcripts in 8-wk 
fetal liver cells directly analyzed ex vivo by PCR provided 
evidence that new genetic programs were initiated in vitro 
in fetal liver precursors after coculture with thymic epithelial 
cells, and formally ruled out a possible outgrowth of a small 
contaminating subset of mature T  cells.  In addition,  they 
could suggest the functional implication of the II.-2 pathway 
in the proliferation and the initiation of the T cell differenti- 
ation program in early thymic immigrants coming from the 
liver. However, the recent observation of phenotypically ma- 
ture T cell populations in I1,2-deficient mice (76) indicates 
that I1.-2 is neither sufficient, nor essential, for T  lympho- 
cyte development and, therefore, other cytokines produced 
in the thymus may functionally replace the missing I1,2. The 
inductive signals involved in the differentiation program ob- 
served in vitro appeared to be delivered upon close cell-to- 
cell interactions, rather than by epithelium-derived soluble 
mediators, since cytokines produced by the ET-VII epithelial 
cells, including I1,3, I1,6, and IL.7, failed to induce the differen- 
tiation of fetal liver cells into mature CD3-TCK + lympho- 
cytes. Neither did those cytokines induce differentiation of 
CD3-TCR + mature T  cells in the presence of thymic epi- 
thelial cells, although acquisition of some T cell markers, such 
as CD7 and I1,2Ro~, was detected in those cultures, as well as 
in cultures set up in the presence of thymic epithelium without 
exogenous cytokine supplementation (our unpublished results). 
These data are in agreement with previously reported data 
on the important role that interaction with the thymic epi- 
thdium plays in the induction of the I1,2Kc~ gene (7). 
Finally,  the absence of detectable CD8+CD4 + double- 
positive calls at different time points from the onset of our 
cultures would suggest that this subset does not significantly 
contribute to the generation of TCK cffB-expressing ma- 
ture T cells from fetal liver precursors. However, the possi- 
bility that a small number of double-positive cells, not de- 
tected in our study, do serve as T  call progenitors cannot 
be excluded considering that most cells within the double- 
positive subset die rapidly in culture, as they do in vivo (77). 
Another important question is whether the requirements for 
the generation of CD4 + or CD8 + single-positive mature T 
cells are different. This seems very likely in view of our results 
showing that differentiation of CD4 + ceils is preferentially 
driven in our culture conditions. As previously proposed (47, 
49), this could reflect the existence of functionally distinct 
types of epithelial cells within the thymic microenvironment, 
influencing the differentiation of T cell precursors into a given 
T cell subset. Establishment of phenotypically and function- 
ally distinct subpopulations of thymic epithelial cells may pro- 
vide a useful experimental system to approach this question 
in the near future. 
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